India's Lupin Recalls Batch Of Blood Pressure Generics From U.S.
This article was originally published in PharmAsia News
Executive Summary
Lupin Ltd. of India agreed to recall a batch of losartan for treating high blood pressure in the U.S. after FDA found it failed to meet impurity standards